Examples
Worked examples
- Is an instance
A head-to-head pragmatic trial randomizes patients to one of two already-FDA-approved anticoagulants, enrolling broadly in ordinary clinic settings, to determine which produces fewer real-world bleeding events -- a CER design, not a placebo-controlled efficacy trial.
- Is an instance
A PCORI-funded observational cohort study compares surgical vs. non-surgical management of a chronic condition using registry data rather than randomization, to characterize which approach performs better under routine care.
Counter-examples
Looks similar, but isn't
- Not an instance
A standard Phase III trial testing a new drug against placebo to establish basic safety and efficacy for FDA approval is not comparative effectiveness research -- it answers whether the treatment works at all, not which of two viable, already-available options works better.
Editorial commentary
Comparative effectiveness research (CER) directly compares two or more existing, already-available healthcare interventions — drugs, devices, procedures, or care-delivery models — against each other under real-world conditions, to determine which works better and for whom. It is a distinct research category from the placebo-controlled efficacy trials that dominate drug development.
How CER differs from an efficacy trial
| Dimension | Standard efficacy trial | Comparative effectiveness research |
|---|---|---|
| Comparator | Placebo or standard of care | Another active, already-available treatment |
| Question answered | Does this treatment work at all? | Which of two (or more) viable options works better, for whom? |
| Population | Narrow, explanatory-trial eligibility criteria | Broad, often pragmatic real-world eligibility |
| Typical design | Randomized, blinded, placebo arm | Head-to-head RCT, pragmatic trial, or observational/registry study |
Study designs used in CER
- Head-to-head randomized trials comparing two active interventions directly
- Pragmatic trials, which relax the narrow eligibility criteria of an explanatory trial to better reflect real-world practice — see also the design comparison in Superiority, Non-Inferiority and Equivalence Trials and the related Equivalence Trial concept
- Observational and registry-based studies, weighed against randomized designs in RCT vs. Observational Study: Design, Evidence Strength & When to Use Each
- Systematic reviews and meta-analyses that synthesize existing head-to-head and observational evidence
A well-specified CER protocol typically defines its question using the same structured framework covered in PICOTS Criteria (Population, Interventions, Comparators, Outcomes, Timing, Setting) — the “Comparators” and “Setting” elements are where CER’s real-world, head-to-head design shows up most clearly relative to a standard efficacy protocol. CER also commonly draws on late-phase clinical study data collected after a product is already on the market.
Who funds and uses CER
In the United States, the Patient-Centered Outcomes Research Institute (PCORI) — a nonprofit authorized and funded under the Patient Protection and Affordable Care Act of 2010 — is the principal funder of CER and the closely related patient-centered outcomes research (PCOR), which adds patient and stakeholder engagement to the comparative-effectiveness question. Research administrators supporting CER protocols should expect funder-specific requirements around patient/stakeholder engagement and real-world data infrastructure that differ from a standard NIH efficacy-trial application.
Frequently asked questions
Is comparative effectiveness research the same as a clinical trial?
Not necessarily. CER can use randomized designs (head-to-head or pragmatic trials) or non-randomized designs (observational/registry studies, systematic reviews) — what defines CER is the comparative, real-world-effectiveness question, not any single study design.
How is CER different from cost-effectiveness research?
CER compares clinical/health outcomes between interventions; cost-effectiveness research adds an economic dimension (cost per outcome achieved). The two are often related but are not the same analysis.
Who funds comparative effectiveness research in the US?
PCORI is the principal dedicated funder, alongside CER-relevant funding streams at NIH and AHRQ.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Comparative Effectiveness Research (CER)"
vocab-term-identifier="https://casrai.org/dictionary/term/comparative-effectiveness-research" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/comparative-effectiveness-research",
"name": "Comparative Effectiveness Research (CER)",
"identifier": "https://casrai.org/dictionary/term/comparative-effectiveness-research",
"description": "Comparative effectiveness research (CER) is a category of clinical and health-services research that directly compares two or more existing, already-in-use healthcare interventions -- drugs, devices, procedures, or care-delivery models -- against each other, rather than against placebo, to determine which works better, for which patients, and under real-world practice conditions. CER differs from a standard efficacy trial in comparator (active treatment vs. active treatment, not treatment vs. placebo) and often in study population (broad, pragmatic real-world eligibility criteria rather than a narrow explanatory-trial population). Methods used to conduct CER include pragmatic randomized trials, head-to-head RCTs, observational and registry-based studies, and systematic reviews/meta-analyses synthesizing existing comparative evidence. In the US, the Patient-Centered Outcomes Research Institute (PCORI) -- a nonprofit authorized and funded under the Patient Protection and Affordable Care Act of 2010 -- is the principal funder of CER and the related patient-centered outcomes research (PCOR).",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/clinical-research#set",
"url": "https://casrai.org/dictionary/term/comparative-effectiveness-research",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"author": {
"@id": "https://casrai.org/#editorial-team"
},
"datePublished": "2026-09-01T00:59:03",
"dateModified": "2026-09-01T00:59:03",
"inLanguage": "en-GB",
"isAccessibleForFree": true
}
